EditorialKommentar
Penicillin delabeling
Annals of Allergy, Asthma & Immunology · 2023
DOI: 10.1016/j.anai.2023.02.024 ↗Kurz gefasst
Editorial in der Zeitschrift Annals of Allergy, Asthma & Immunology, 2023. Verfasst von Kevin M White. Beteiligte Einrichtung: Allergy & Immunology Clinic, Wilford Hall Ambulatory Surgical Center, San Antonio, Texas. Electronic address: kevin.m.white54.mil@health.mil. Hauptthemen laut MEDLINE: Penicillins, Drug Hypersensitivity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
PenicillinsDrug HypersensitivityHumansChildAnti-Bacterial AgentsPrimary Health Care
Substanzen
PenicillinsAnti-Bacterial Agents
Autor:innen und Institutionen
- Allergy & Immunology Clinic, Wilford Hall Ambulatory Surgical Center, San Antonio, Texas. Electronic address: kevin.m.white54.mil@health.mil.
Zitieren
APA
White, K. M. (2023). Penicillin delabeling. Annals of Allergy, Asthma & Immunology. https://doi.org/10.1016/j.anai.2023.02.024
Vancouver
White KM. Penicillin delabeling. Annals of Allergy, Asthma & Immunology. 2023. doi:10.1016/j.anai.2023.02.024
BibTeX
@article{White2023,
author = {White, Kevin M},
title = {Penicillin delabeling},
journal = {Annals of Allergy, Asthma & Immunology},
year = {2023},
doi = {10.1016/j.anai.2023.02.024}
}
EUVIMED